CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

No InterventionWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (12)

Name (Synonyms) Correlation
drug546 ChAdOx1 nCoV-19 full boost Wiki 0.58
drug1465 MenACWY Wiki 0.58
drug1224 Interferon-Beta Wiki 0.58
drug1759 Paracetamol Wiki 0.58
drug1466 MenACWY boost Wiki 0.58
drug547 ChAdOx1 nCoV-19 half boost Wiki 0.58
drug3048 vv-ECMO only (no cytokine adsorption) Wiki 0.41
drug3047 vv-ECMO + cytokine adsorption (Cytosorb adsorber) Wiki 0.41
drug542 ChAdOx1 nCoV-19 Wiki 0.41
drug217 Aspirin Wiki 0.41
drug2105 Rivaroxaban Wiki 0.33
drug601 Colchicine Wiki 0.20

Correlated MeSH Terms (3)

Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.07
D045169 Severe Acute Respiratory Syndrome NIH 0.06
D011014 Pneumonia NIH 0.03

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.03

There are 3 clinical trials

Clinical Trials

1 COVID-19 Symptom Tracker

The viral Covid-19 outbreak is now considered a pandemic according to the World Health Organisation (WHO). A free monitoring app 'COVID-19 Symptom Tracker' has been developed to record and monitor the symptoms of the COVID-19 coronavirus infection; tracking in real time how the disease progresses. The app also records how measures aimed at controlling the pandemic including self-isolation and distancing are affecting the mental health and well-being of participants. The data from the study will reveal important information about the symptoms and progress of COVID-19 infection in different people, and why some go on to develop more severe or fatal disease while others have only mild symptoms do not.

NCT04331509 COVID-19 Other: No Intervention

Primary Outcomes

Description: Self reported as physically healthy (tick box)

Measure: Physical health symptoms

Time: 1 day

Description: Self reported as physically not feeling healthy (tick box)

Measure: Lack of physical health symptoms

Time: 1 day

Secondary Outcomes

Description: Self reported remperature (Degrees Celsius)

Measure: Fever

Time: 1 day

Other Outcomes

Description: Self reported cough (drop down menu; yes/no)

Measure: Cough

Time: 1 day

Description: Self reported fatigue (drop down menu; yes/no)

Measure: Fatigue

Time: 1 day

Description: Self reported headache (drop down menu; yes/no)

Measure: Headache

Time: 1 day

Description: Self reported shortness of breath (drop down menu; yes/no)

Measure: Shortness of breath

Time: 1 day

Description: Self reported sore throat (drop down menu; yes/no)

Measure: Sore throat

Time: 1 day

Description: Self reported loss of smell/ taste (drop down menu; yes/no)

Measure: Loss of smell/ taste

Time: 1 day

Description: Self reported hoarse voice (drop down menu; yes/no)

Measure: Hoarse voice

Time: 1 day

Description: Self reported chest pain or tightness (drop down menu; yes/no)

Measure: Chest pain or tightness

Time: 1 day

Description: Self reported abdominal pain (drop down menu; yes/no)

Measure: Abdominal pain

Time: 1 day

Description: Self reported diarrhoea (drop down menu; yes/no)

Measure: Diarrhoea

Time: 1 day

Description: Self reported confusion (drop down menu; yes/no)

Measure: Confusion

Time: 1 day

Description: Self reported skipping meals (drop down menu; yes/no)

Measure: Skipping meals

Time: 1 day

2 AiM COVID for Covid 19 Tracking and Prediction

University of Warwick (Coventry, UK) and NTUU "Igor Sikorsky" Kyiv Polytechnic Institute (Kyiv, Ukraine), together with ClickMedix LLC, have developed an app and a chatbot "AiM COVID" for efficient monitoring and mitigation of COVID-19. These products are available for free download on computers and mobile phones. These can be used by a wide range of users from various sectors - patients and people living with them, doctors, nurses, specialists, community health workers, hospitals, clinics, hospital IT staff, MHFA, and insurance companies.

NCT04354753 COVID 19 Other: No Intervention

Primary Outcomes

Description: Self reported physical symptoms

Measure: Physical symptoms

Time: 1day

Description: Contact with suspected, confirmed or ill person

Measure: Contact History

Time: 14 days

Description: Travel to or from overseas

Measure: Travel History

Time: 14 days

Secondary Outcomes

Description: Self reported body temperature

Measure: Fever

Time: 1 day

Description: Self reported headache using yes/no

Measure: Headache

Time: 1 day

Description: Self reported soar throat using yes/no

Measure: Soar Throat

Time: 1 day

Description: Self reported runny nose using yes/no

Measure: Runny nose

Time: 1 day

Description: Self reported cough using yes/no

Measure: Cough

Time: 1 day

Description: Self reported shortness of breath symptoms using yes/no

Measure: Shortness of breath

Time: 1 day

Description: Self reported nausea using yes/no

Measure: Nausea

Time: 1 day

Description: Self reported vomiting using yes/no

Measure: Vomiting

Time: 1 day

Description: Self reported muscle pain using yes/no

Measure: Muscle pain

Time: 1 day

Description: Self reported joint pain using yes/no

Measure: Joint pain

Time: 1 day

Description: Self reported Diarrhoea using yes/no

Measure: Diarrhoea

Time: 1 day

Description: Self reported other symptoms using yes/no

Measure: Other

Time: 1 day

Description: Self reported hospitalisation using yes/no

Measure: Hospitalisation history

Time: 1 day

Description: Self reported co-morbid conditions using checked box

Measure: Co-morbid conditions

Time: 1 day

3 COVID-19 Disease in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care in the Hamburg Metropolitan Area Including Prospective Biobanking

The COVIDHELP study will prospectively evaluate the yet unknown clinical course of the COVID-19 infection in cancer patients and document the impact of potential infrastructural limitations on cancer care of COVID-19 positive patients. All patients consenting will provide peripheral blood samples for prospective biobanking with the aim of investigating immune response and immunity against COVID-19.

NCT04408339 Cancer COVID Other: No Intervention

Primary Outcomes

Description: Measured in percentage

Measure: Rate of hospitalization

Time: 2 years

Description: Measured in days from date of admission to definitive discharge

Measure: Duration of hospitalization

Time: 2 years

Description: Measured in percentage

Measure: Rate of admission to intensive care unit

Time: 2 years

Description: Measured in days from date of admission to intensive care unit to the date of discharge

Measure: Length of stay in intensive care unit

Time: 2 years

Description: Measured in percentage

Measure: Need of mechanical ventilation

Time: 2 years

Description: Measured in days from the date of intubation to the stop date of mechanical ventilation

Measure: Duration of mechanical ventilation

Time: 2 years

Description: COVID-19 associated mortality rate

Measure: Disease-specific mortality rate

Time: 2 years

Secondary Outcomes

Description: Measured in percentage. Modification is defined as cancellation, postponement or dose-adjustment of treatment.

Measure: Rate of patients, whose oncologic treatment had to be modified due to COVID-19

Time: 2 years

Description: Analysis of blood samples at time of diagnosis and after 6 month

Measure: Cellular and humoral immune response to COVID-19 infection

Time: 6 month

No related HPO nodes (Using clinical trials)